Drs. El Saafien and Morris awarded American Heart Association Fellowships
El Saafien received a two-year postdoctoral fellowship, while Morris was awarded a one-year predoctoral fellowship.
Posted in
Pharmaceutical Outcomes News
Study: Election stress might impact health
A study led by Dr. Steven Smith suggests population-level blood pressure, particularly among racial and ethnic minorities, might have increased following the 2016 presidential election.
Dr. Almut Winterstein elected to the Academy of Science, Engineering and Medicine of Florida
Fourteen members of the class of 2022 were officially inducted at the ASEMFL Annual Meeting in Orlando on Nov. 5.
UF Health researchers find quinolone ear drops associated with tendon ruptures
Research by Patrick Antonelli, M.D., and Almut Winterstein, Ph.D., shows quinolone ear drops used to treat infection increase the risk of tendon ruptures.
Dr. Winterstein honored with special ISPE award for COVID-19 pandemic contributions
Dr. Winterstein was one of nine ISPE members honored with the award at the 38th International Conference on Pharmacoepidemiology & Therapeutic Risk Management in Copenhagen, Denmark.
Academic Kickoff celebration welcomes new Gators to the college
The annual event took place Sept. 19 at the UF Hilton Conference Center.
Peter Swaan named dean of the UF College of Pharmacy
Swaan becomes the eighth dean of the college in its 99-year history.
UF model investigates how drug interactions lead to contraceptive failure
The model will help regulators, as well as the pharmaceutical industry, evaluate the best- and worst-case scenarios when hormonal contraceptives are prescribed with new drug candidates.
UF College of Pharmacy researchers aim to improve health equity in diabetes care
A four-year study aims to identify the patient groups who would benefit most from newer glucose-lowering drugs.
Dr. Hui Shao awarded $2.8 million grant to improve enrollment in the National Diabetes Prevention Program
The project aims to identify barriers and facilitators to the enrollment and completion of the National Diabetes Prevention Program and evaluate its long-term effectiveness and cost-effectiveness.
